Body fat distribution could be a key predictor of heart disease risk in postmenopausal women, according to a July 1 study that found “apple”-shaped women are more prone to CVD than their “pear”-shaped counterparts.

Sportswear brand Under Armour filed a patent application this week for a new “smart” shoe that’s able to take a wearer’s blood pressure and help them recover faster from a workout.

Patients prescribed statins for CV risk reduction are more than twice as likely to develop type 2 diabetes compared to non-statin users, a study out of Ohio State University has found.

Online pharmacy Valisure on June 13 issued a letter to the FDA after in-house testing revealed dangerously elevated levels of N,N-Dimethylformamide (DMF) in certain lots of valsartan, an angiotensin II receptor blocker (ARB) commonly used to treat hypertension and heart failure.

Inadequate fruit and vegetable consumption contributes to nearly 2 million CV-related deaths each year, according to research presented at Nutrition 2019, the American Society for Nutrition’s annual meeting, in Baltimore.

The antihypertensive drug nilvadipine may benefit Alzheimer’s patients by encouraging blood flow to the brain, slowing the progression of the disease while reducing blood pressure in the hippocampus, researchers reported in Hypertension June 17.

A 25-minute steam in the sauna could be just as beneficial for heart health as a moderate physical workout, researchers at Martin Luther University Halle-Wittenberg and the Medical Center Berlin have found.

Teva Pharmaceuticals is pulling six bulk lots of its angiotensin II receptor blocker losartan from the market after testing revealed dangerously high levels of N-Nitroso-N-methyl-4-aminobutyric acid, a probable human carcinogen, in the drugs.